Jianyuan Deng

Jianyuan Deng

Auto-generated profile, based on publicly available information

Jianyuan Deng

Stony Brook University, Department of Biomedical Informatics, Stony Brook, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JDJianyuan Deng
Jianyuan Deng
ZYZhibo Yang
Zhibo Yang
HWHehe Wang
Hehe Wang
IOIwao Ojima
Iwao Ojima
DSDimitris Samaras
Dimitris Samaras
FWFusheng Wang
Fusheng Wang
Artificial intelligence (AI) has been widely applied in drug discovery with a major task as molecular property prediction. Despite booming techniques in molecular representation learning, key elements underlying molecular property prediction remain largely unexplored, which impedes further advancements in this field. Herein, we conduct an extensive evaluation of representative models using various representations on the MoleculeNet datasets, a suite of opioids-related datasets and two additional activity datasets from the literature. To investigate the predictive power in low-data and high-data space, a series of descriptors datasets of varying sizes are also assembled to evaluate the models. In total, we have trained 62,820 models, including 50,220 models on fixed representations, 4200 models on SMILES sequences and 8400 models on molecular graphs. Based on extensive experimentation and rigorous comparison, we show that representation learning models exhibit limited performance in molecular property prediction in most datasets. Besides, multiple key elements underlying molecular property prediction can affect the evaluation results. Furthermore, we show that activity cliffs can significantly impact model prediction. Finally, we explore into potential causes why representation learning models can fail and show that dataset size is essential for representation learning models to excel.

1 April 2021 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
XDXinyu Dong
Xinyu Dong
JDJianyuan Deng
Jianyuan Deng
WHWei Hou
Wei Hou
SRSina Rashidian
Sina Rashidian
RRRichard N. Rosenthal
Richard N. Rosenthal
FWFusheng Wang
Fusheng Wang

30 April 2021 in Journal of the American Medical Informatics Association
Verified
Journal Article
Closed access
PDF file
XDXinyu Dong
Xinyu Dong
JDJianyuan Deng
Jianyuan Deng
SRSina Rashidian
Sina Rashidian
KAKayley Abell-Hart
Kayley Abell-Hart
WHWei Hou
Wei Hou
FWFusheng Wang
Fusheng Wang
Objective: The United States is experiencing an opioid epidemic. In recent years, there were more than 10 million opioid misusers aged 12 years or older annually. Identifying patients at high risk of opioid use disorder (OUD) can help to make early clinical interventions to reduce the risk of OUD. Our goal is to develop and evaluate models to predict OUD for patients on opioid medications using electronic health records and deep learning methods. The resulting models help us to better understand OUD, providing new insights on the opioid epidemic. Further, these models provide a foundation for clinical tools to predict OUD before it occurs, permitting early interventions. Methods: Electronic health records of patients who have been prescribed with medications containing active opioid ingredients were extracted from Cerner’s Health Facts database for encounters between January 1, 2008, and December 31, 2017. Long short-term memory models were applied to predict OUD risk based on five recent prior encounters before the target encounter and compared with logistic regression, random forest, decision tree, and dense neural network. Prediction performance was assessed using F1 score, precision, recall, and area under the receiver-operating characteristic curve. Results: The long short-term memory (LSTM) model provided promising prediction results which outperformed other methods, with an F1 score of 0.8023 (about 0.016 higher than dense neural network (DNN)) and an area under the receiver-operating characteristic curve (AUROC) of 0.9369 (about 0.145 higher than DNN). Conclusions: LSTM–based sequential deep learning models can accurately predict OUD using a patient’s history of electronic health records, with minimal prior domain knowledge. This tool has the potential to improve clinical decision support for early intervention and prevention to combat the opioid epidemic.

17 December 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
SRSina Rashidian
Sina Rashidian
KAKayley Abell-Hart
Kayley Abell-Hart
JHJanos Hajagos
Janos Hajagos
RMRichard Moffitt
Richard Moffitt
VLVeena Lingam
Veena Lingam
MSMary Saltz
Mary Saltz
Background: Diabetes affects more than 30 million patients across the United States. With such a large disease burden, even a small error in classification can be significant. Currently billing codes, assigned at the time of a medical encounter, are the “gold standard” reflecting the actual diseases present in an individual, and thus in aggregate reflect disease prevalence in the population. These codes are generated by highly trained coders and by health care providers but are not always accurate. Objective: This work provides a scalable deep learning methodology to more accurately classify individuals with diabetes across multiple health care systems. Methods: We leveraged a long short-term memory-dense neural network (LSTM-DNN) model to identify patients with or without diabetes using data from 5 acute care facilities with 187,187 patients and 275,407 encounters, incorporating data elements including laboratory test results, diagnostic/procedure codes, medications, demographic data, and admission information. Furthermore, a blinded physician panel reviewed discordant cases, providing an estimate of the total impact on the population. Results: When predicting the documented diagnosis of diabetes, our model achieved an 84% F1 score, 96% area under the curve–receiver operating characteristic curve, and 91% average precision on a heterogeneous data set from 5 distinct health facilities. However, in 81% of cases where the model disagreed with the documented phenotype, a blinded physician panel agreed with the model. Taken together, this suggests that 4.3% of our studied population have either missing or improper diabetes diagnosis. Conclusions: This study demonstrates that deep learning methods can improve clinical phenotyping even when patient data are noisy, sparse, and heterogeneous.

11 August 2014 in Journal of Polymer Science Part A: Polymer Chemistry
Verified
Journal Article
Open access
PDF file
Jian HeJian He
Jian He
Dong ChenDong Chen
Dong Chen
KHKai Han
Kai Han
XHXiaoxia Huang
Xiaoxia Huang
LWLiwei Wang
Liwei Wang
WYWantai Yang
Wantai Yang
Poly(divinylbenzene‐alt‐maleic anhydride) nanoparticles with a narrow distribution and a diameter of 30 nm act as novel stabilizers in the Pickering emulsion polymerization of styrene. The hydrolyzed PDMNPs with NaHCO3 aqueous solution exhibited a very effective emulsification performance and a remarkably high emulsification efficiency. Raspberry‐like PDMNPs/PS composite polymer particles have been successfully fabricated via copolymerization of pendant vinyl groups of PDMNPs with styrene.

9 July 2004 in Journal of Polymer Science Part A: Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
PYPeng Yang
Peng Yang
YSYufeng Sun
Yufeng Sun
JDJianyuan Deng
Jianyuan Deng
WLWeina Liu
Weina Liu
LZLi Zhang
Li Zhang
WYWantai Yang
Wantai Yang